Vol 29, No 4 (2026)
- Year: 2026
- Published: 10.09.2026
- Articles: 11
- URL: https://rjsvd.com/1560-9588/issue/view/14443
- DOI: https://doi.org/10.17816/dv.294
DERMATOLOGY
A modern approach to the differential diagnosis of erythrodermic pityriasis rubra pilaris: a retrospective study. Part 2
Abstract
BACKGROUND: Pityriasis rubra pilaris (Devergie disease) is a rare chronic inflammatory skin disease belonging to the group of papulosquamous dermatoses, clinically characterized by erythematous papules and plaques with frequent development of erythroderma. Erythroderma can also be observed in psoriasis and cutaneous T-cell lymphoma (mycosis fungoides). These diseases may have similar clinical manifestations; however, the histological signs of erythroderma are often non-specific, which complicates verification of the diagnosis. Furthermore, when mycosis fungoides is suspected, additional diagnostic methods and the development of a differential diagnostic algorithm for diseases presenting with erythroderma are required.
AIM: To conduct a comparative analysis of clinical, anamnestic, histological, and immunohistochemical features of the erythrodermic form of pityriasis rubra pilaris, psoriasis, and mycosis fungoides based on published data and the results of our study, with the subsequent development of a differential diagnostic algorithm for erythroderma.
METHODS: The study involved a review of data published in 2000–2025 using the PubMed, Scopus, and Google Scholar databases, as well as the results of a clinical and epidemiological study conducted in 2014–2024.
RESULTS: According to published data, erythroderma develops in a significant proportion of patients with pityriasis rubra pilaris, whereas in psoriasis it is observed in 1–2.25% of cases, and in late-stage mycosis fungoides — in 17.3% of patients. Pityriasis rubra pilaris is characterized by a bimodal age incidence peak: the first peak occurs in childhood, the second in adulthood. The onset of the disease is usually acute or subacute. The rash typically shows caudal spread with possible spontaneous regression. Key differential diagnostic features of pityriasis rubra pilaris are salmon-colored plaques that coalesce to develop erythroderma, the presence of "islands" of spared skin, palmoplantar keratoderma, and alopecia. It was previously believed that a positive response to systemic retinoids combined with an absent or minimal response to phototherapy could be considered an important clinical diagnostic criterion favoring pityriasis rubra pilaris in the differential diagnosis from psoriasis and mycosis fungoides. However, resistance and insufficient response to systemic retinoid therapy are currently being reported with increasing frequency.
CONCLUSION: Differential diagnosis of the erythrodermic form of pityriasis rubra pilaris, psoriasis, and mycosis fungoides requires an integrated approach, based on clinical and anamnestic data analysis and the results of laboratory and instrumental diagnostic methods. The proposed algorithm for the differential diagnosis of diseases presenting with erythroderma serves as a valuable tool for accurate and rapid verification of the diagnosis and the prompt selection of targeted therapy.
407-420
Pathogenetic rationale for the use of salmon tissue-derived exosomes in patients with androgenetic alopecia: a prospective, uncontrolled, observational study
Abstract
BACKGROUND: Androgenetic alopecia is the most common form of non-cicatricial alopecia with a genetic predisposition and polygenic inheritance. This condition is characterized by progressive miniaturization of terminal hairs in androgen-dependent areas under the influence of dihydrotestosterone, leading to their replacement with vellus hairs and a significant impairment in quality of life. First-line therapies for androgenetic alopecia are minoxidil and 5α-reductase inhibitors; however, an increasing number of cases with insufficient response to standard therapy have recently been reported, driving the search for innovative, pathogenetically grounded approaches based on the principles of regenerative medicine, in particular exosome administration.
AIM: To evaluate the efficacy and pathogenetic rationale of salmon-derived exosomes in patients with androgenetic alopecia based on phototrichogram data and expression of cellular proliferation (Ki-67) and angiogenesis (CD31+) markers in scalp skin biopsies.
METHODS: A prospective, uncontrolled, observational study was conducted involving 20 patients (14 males with androgenetic alopecia stages III–IV on the Norwood–Hamilton scale and 6 females with stages I–II on the Ludwig scale). All participants received 4 sessions of lyophilized salmon tissue-derived exosomes combined with microneedling at 14-day intervals. Efficacy was assessed before treatment and at week 12 after the last procedure using phototrichogram analysis (ARAMO SG, TrichoScan v. 4.5) and histological/immunohistochemical evaluation of scalp biopsies (markers: Ki-67, CD31).
RESULTS: Following the use of salmon tissue-derived exosomes, a statistically significant increase in hair density of 44.4 hairs/cm2 (p < 0.001), was observed; the proportion of vellus hairs decreased from 40.4% to 3.4% (p = 0.005); mean hair shaft diameter increased by 22.4 µm (p < 0.001); and the proportion of anagen hairs increased by 36.4% (p < 0.001). Histological examination confirmed an increase in terminal follicular density (+1.4 follicles/mm2; p < 0.001) and normalization of the terminal-to-vellus ratio (T/V) from 2.3 to 9.6; (p < 0.001). Immunohistochemistry revealed a significant increase in Ki-67 proliferation in the outer root sheath (+55.5%; p < 0.001) and CD31+ (angiogenesis marker) (+11.5 vessels per field of view; p < 0.001). No adverse reactions were recorded.
CONCLUSION: The use of salmon tissue-derived exosomes combined with microneedling has demonstrated preliminary evidence of good tolerability and positive cosmetic outcomes in patients with androgenetic alopecia. The results are supported by restoration of the functional reserve of hair follicles, a significant reduction in hair miniaturization, normalization of the microenvironment (including improved angiogenesis and reduced inflammation), a significant increase in terminal hair density, and prolongation of the anagen phase, which supports the promise of exosomes as a cell-free regenerative approach in clinical trichology; however, future large randomized controlled trials are required to confirm their efficacy in patients with androgenetic alopecia.
421-432
Comparison of efficiency and safety profile of home-based versus outpatient modalities of NB-UVB 311 phototherapy in the treatment of vitiligo
Abstract
Vitiligo is a chronic skin disorder where the loss of melanocytes results into repigmentation areas on the skin. Narrowband Ultraviolet B (NB-UVB) 311 nm phototherapy, characterized by its efficacy and safety, is widely accepted as an effective treatment of vitiligo with repigmentation stabilization. This review compares the efficacy and safety of home-based NB-UVB therapy versus outpatient NB-UVB therapy. On the one hand, both procedures show comparable efficacies for producing significant repigmentation. In this sense, home-based therapy has the added advantages of convenience and flexibility while representing a real transformation from traditional model to modern pattern. But the success of home-based therapy depends highly on proper patient education and adherence to treatment protocols and regular monitoring to prevent misuse as well as potential adverse effects. Outpatient therapy provides the benefit of professional supervision, so that accurate dosing can be ensured and immediate intervention in case of any side effect can be given, thus making it more suitable for patients with complex medical conditions. The review also highlights the importance of telemedicine in enhancing the feasibility and safety of home-based therapy by allowing remote monitoring and as well as real-time support telemedicine. This allows for increased compliance with patients due to the convenience and flexibility while still offering an alternative therapy method when access to healthcare facilities is lacking. It can be expected that future developments in the field of telemedicine will increasingly improve safety and feasibility while performing therapy at home. It is a matter of using these modalities based on patient-specific needs, wants and circumstances to ensure that every patient receives appropriate care most effective for their condition. Future research should focus on evaluating the cost-effectiveness of both modalities and ways to integrate advanced monitoring technologies into home care. Ultimately, the choice between home-based and out-patient NB-UVB therapy should be tailored to individual patient needs, thus ensuring the best possible treatment results.
433-441
Comparative analysis of quality of life and social adaptation of patients with psoriasis with various therapeutic approaches
Abstract
Psoriasis is a chronic immune-mediated skin disease with a global prevalence ranging from 0.6 to 4.8% of the population, which significantly reduces patients' quality of life. The severity of the skin condition does not always determine the patient's subjective well-being, while psychological factors, body image, and access to social resources are often more significant determinants of adaptation. Patients with psoriasis demonstrate pronounced psychological heterogeneity: some patients show a marked decrease in life satisfaction, while others maintain a level of subjective well-being comparable to that of healthy individuals. This variability is largely determined by the profile of psychosocial resources and body image perception rather than by objective clinical indicators.
This review summarizes data on changes in quality of life and social adaptation in patients with psoriasis following various therapeutic strategies, including topical therapy, phototherapy, systemic immunosuppressive drugs, and biological therapy. It has been shown that biological agents provide the most significant improvement in both clinical and patient-oriented indicators. However, they do not automatically eliminate psychological disturbances, which persist even after deep clinical remission has been achieved. The phenomenon of psychological lag, in which improvements in anxiety, depression, and self-esteem indicators trail behind skin clearance by several weeks or months, justifies the need for targeted psychological support at all stages of treatment.
An analysis of work adaptation suggests that productivity losses in psoriasis are largely due to presenteeism rather than absenteeism, with losses from reduced workplace productivity on average two to three times greater than losses from forced absences from work. The practical characteristics of the treatment regimen, particularly the frequency of visits, the route of drug administration, and its tolerability, independently contribute to the patient's overall quality of life and work rehabilitation.
It was concluded that an integrated approach combining pharmacological treatment with psychological interventions aimed at strengthening the patient's psychosocial resources and fostering a positive body image is needed. The application of a person-centered methodological approach, specifically latent profile analysis, opens up opportunities for a more differentiated understanding of patients' psychological well-being and the development of targeted therapeutic strategies.
442-451
Association of IL-2 (-330 T/G) and JAK2 Val612Phe polymorphisms with the risk and severity of atopic dermatitis: a controlled, non-randomized case-control study
Abstract
BACKGROUND: Atopic dermatitis (AtD) is a chronic inflammatory skin disease. Despite the well-established role of cytokines, including interleukin-2 (IL-2), and the JAK-STAT signaling pathway in its pathogenesis, the contribution of IL-2 (-330 T/G, rs2069762) and Janus kinase (JAK) 2 (Val612Phe) gene polymorphisms to disease severity remains poorly understood, particularly in specific populations. Data on the relationship between these genetic variants and the clinical course of atopic dermatitis are lacking, limiting the potential for a personalized approach to risk assessment and disease prognosis.
AIM: To investigate the distribution of alleles and genotypes of IL-2 (-330 T/G, rs2069762) and JAK2 (Val612Phe) polymorphisms in patients with AtD and to evaluate their association with disease severity.
METHODS: This study included 157 patients with atopic dermatitis and 72 healthy controls. Disease severity was assessed using the Scoring Atopic Dermatitis index (SCORAD). Genotyping of IL-2 (-330 T/G, rs2069762) and JAK2 (Val612Phe) polymorphisms was performed by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis following genomic DNA extraction from peripheral blood. The primary endpoint was the association of these polymorphisms with AtD presence and severity; secondary endpoints included allele and genotype frequencies in the study groups. Statistical analysis comprised comparisons of allele and genotype frequencies, calculation of odds ratios with 95% CI, and assessment of Hardy–Weinberg equilibrium (p < 0.05).
RESULTS: JAK2 Val612Phe allele frequencies in the overall sample were similar to those in controls (G > 97%); no statistically significant associations with AtD or severity were observed (p > 0.05). For the IL-2 (-330 T/G) polymorphism, the frequency of the GG homozygotes was higher in patients than in controls (16.6% vs 6.9%, respectively). GG carriage was associated with an increased risk of AtD (OR = 2.66; p = 0.048). In patients with severe disease, the association between GG and disease severity was stronger (OR = 4.0; p = 0.025). No study-related adverse events were recorded. These results should be interpreted in light of study limitations, including the small sample size and the lack of functional data on the effect of the -330G variant on IL-2 expression.
CONCLUSION: In this population, the IL-2 -330 T/G polymorphism in the GG homozygous state may be associated with an increased risk and greater severity of AtD, whereas JAK2 Val612Phe showed no significant effect. These findings warrant confirmation in larger, more representative cohorts and, where possible, in functional studies of the -330G variant on IL-2 expression.
452-460
Low-temperature argon plasma in combination therapy for non-segmental vitiligo
Abstract
BACKGROUND: Narrowband Ultraviolet B 311 nm (UVB-311 nm) therapy is a first-line treatment for non-segmental vitiligo, but repigmentation is slow, and in some patients, the therapeutic effect remains insufficient even with long-term treatment. Data on the use of low-temperature argon plasma in combination with phototherapy for non-segmental vitiligo are virtually nonexistent, although the complementary mechanisms of both methods justify their combination.
AIM: To evaluate the efficacy and safety of the combined use of low-temperature argon plasma and UVB-311 nm compared with UVB-311 nm monotherapy in patients with non-segmental vitiligo, based on changes in the VASI (Vitiligo Area Severity Index) and quality of life (Vitiligo-Specific Quality of Life, VitiQoL) over 8 weeks and 1 month after treatment completion.
METHODS: A prospective, non-randomized, controlled, comparative trial included adult patients with non-segmental vitiligo with depigmented lesions assessed by VASI. A total of 60 patients were included in the study: 28 in the main group and 32 in the control group. In the main group, the median age was 34.5 years [Q1; Q3: 26.0; 44.0], in the control group 36.0 years [28.0; 46.5]; women accounted for 60.7% and 62.5%, respectively. The median duration of the disease in the main group was 4.5 years [2.0; 9.0], in the control group 5.0 years [2.5; 10.0]; a history of five years or more was observed in 42.9% and 50.0% of the participants, respectively. The groups were comparable for all baseline parameters; no statistically significant intergroup differences were found. Patients with segmental and mixed forms of the disease, pregnant women, individuals with photodermatoses, a history of systemic immunosuppressants, and skin cancer were excluded. The main group received low-temperature argon plasma therapy on depigmented lesions using the Plasmoran device, followed by a session of UVB-311 nm. The control group received UVB-311 nm monotherapy. Treatment was administered three times a week for 8 weeks. Evaluations were performed at baseline, after 4 and 8 weeks, and 1 month after completion of therapy.
RESULTS: In the main group, the median VASI score decreased from 3.8 to 2.3 points by week 8 (a 39.5% decrease), and in the control group from 4.1 to 3.1 points (24.4%); the difference between groups was 0.5 points (95% CI 0.04–0.96; p = 0.03). After 1 month, the difference remained (2.1 versus 2.9 points, p = 0.04). According to VitiQoL, the median score at week 8 was 30.5 versus 35.0 points (p = 0.04), and after 1 month, 28.0 versus 33.5 points (p = 0.03). The advantage of the combination regimen was significant for non-acral locations and disease durations of less than 5 years. Adverse events were reported in 7 of 28 patients in the main group and 5 of 32 in the control group; all were transient and resolved spontaneously.
CONCLUSION: The combination of low-temperature argon plasma with UVB-311 nm therapy provides a significantly greater reduction in VASI and improvement in quality of life compared to monotherapy. This is a pilot, non-randomized trial with a short follow-up, which limits the validity of the conclusions and requires a randomized controlled trial.
461-472
Primary incidence of psoriasis in the Russian Federation
Abstract
BACKGROUND: Psoriasis is a chronic multifactorial dermatosis that poses a serious medical and social problem. It occurs with virtually equal frequency in women and men, and there is a hereditary predisposition to its development. The most significant factors in the development of psoriasis are considered to be ethnicity, genetics, and environmental factors, although immune disorders are also possible. Psoriasis, as a disease associated with various comorbidities, including cardiovascular, gastrointestinal, endocrine, and other systems and organs, often causes persistent disability. Early detection and prevention of relapses are an important strategic task for medical specialists.
AIM: To assess the primary incidence of psoriasis in the Russian Federation.
METHODS: An analysis of federal statistical observation forms for 2020–2024, presented in collections of the Ministry of Health of the Russian Federation, was conducted. Primary psoriasis incidence rates in the Russian Federation were calculated.
RESULTS: The study revealed that the average Russian incidence rate of psoriasis for the study period, both in the Russian Federation as a whole and in most federal districts, is trending upward, despite a decline in 2024 compared to the previous year. This upward trend in psoriasis incidence is characteristic of both adults and children. The most unfavorable situation for the general population is found in the Northwestern and Volga Federal Districts, and for children, in the Northwestern and Far Eastern Federal Districts.
CONCLUSION: An increase in primary psoriasis incidence in the Russian Federation was revealed for both adults and children. This indicates the need to study the causes of this increase in incidence and make management decisions on psoriasis prevention among the population.
473-479
Photobiomodulation as an adjuvant approach in the management of seborrheic psoriasis
Abstract
Seborrheic psoriasis involving the scalp is a clinically relevant form of psoriasis because even limited lesions may be associated with marked pruritus, scaling, cosmetic discomfort, and a substantial reduction in quality of life. Management of this location is complicated by the anatomical features of the affected area, reduced convenience of topical treatment, and limitations associated with prolonged use of topical agents. In this context, photobiomodulation, a noninvasive low-intensity light-based intervention using red and near-infrared wavelengths outside the ultraviolet spectrum, has attracted interest.
This review aimed to analyze current data on the role of photobiomodulation in the comprehensive management of scalp involvement in psoriasis. The review was based on publications from 2020 to 2026 identified through Russian- and English-language search queries in the PubMed, Scopus, ResearchGate, and Russian Science Citation Index databases. Clinical guidelines, review articles, as well as experimental and clinical studies addressing photobiomodulation and other light-based methods in dermatology were included. The analysis showed that treatment response in this localization should be assessed not only with Psoriasis Area and Severity Index (PASI), but also with the local Psoriasis Scalp Severity Index (PSSI) combined with patient-reported outcomes, including itch intensity measured by Visual Analogue Scale/Numeric Rating Scale (VAS/NRS) and quality of life assessed by Dermatology Life Quality Index (DLQI).
Experimental evidence suggests that photobiomodulation may influence inflammatory signaling pathways, microcirculation, and keratinocyte hyperproliferation. However, the clinical evidence remains limited because of heterogeneity in irradiation parameters, differences in study design, and insufficient standardization of endpoints. Photobiomodulation may be considered a potential adjuvant option for localized forms of psoriasis, but its clinical role requires further validation in controlled studies.
480-488
Crusted scabies in a patient with down syndrome: a case report
Abstract
Crusted scabies is a highly contagious form of scabies, most often diagnosed in patients with immunodeficiency, peripheral sensory impairment, and cognitive impairment, especially in residential care facilities. The problem is particularly relevant due to the high risk of nosocomial outbreaks and the spread of infection among contacts and staff of institutions where a patient with crusted scabies is identified. The clinical presentation of the disease is nonspecific, complicating timely diagnosis and aggravating its course.
A clinical analysis of crusted scabies in a patient with Down syndrome revealed typical manifestations of the disease: mild itching, hyperkeratotic crusts, scalp lesions, and nail changes. The diagnosis of crusted scabies was confirmed by identifying the mite during microscopic examination of a skin scraping and by histological examination of a skin biopsy from the lesion. Treatment consisted of topical antiparasitic and keratolytic agents, as well as a range of preventive measures, which resulted in the patient's recovery.
It is important to note that patients at risk for developing crusted scabies include those with immunodeficiency, impaired peripheral sensitivity, substance use disorder, long-term use of hormonal and cytostatic drugs, the elderly, and those with significant comorbidities (especially cardiovascular and endocrine diseases). Timely diagnosis and implementation of a full range of medical and non-medical measures to treat scabies and prevent its spread are the foundation of care for this group of patients.
489-496
CHRONICLES
Chronicles of A.I. Pospelov Moscow Society of Dermatovenereologists and Cosmetologists (MSDC was founded on October 4, 1891). Bulletin of the MSDC No. 1166
Abstract
On February 17, 2026, the 1166th meeting of the Moscow Society of Dermatovenereologists and Cosmetologists named after A.I. Pospelov was held in honor of the 180th anniversary of the birth of its founder, Professor Alexey Ivanovich Pospelov.
The meeting was held in person in the Golden Ring Hall conference center at the Golden Ring Hotel. A total of 180 participants attended.
The scientific session featured five reports, the first marking the 180th anniversary of the birth of the founder of the Moscow Society of Dermatovenereologists and Cosmetologists, Professor Alexey Ivanovich Pospelov.
A.I. Pospelov was born on February 9, 1846, in the Ryazan province (Dankov). He graduated from the Medical Faculty of Moscow University with a degree in medicine, but while still a student he was awarded a medal for his essay "On the difference between the effects of potassium iodide and potassium bromide on the animal body." His Doctor of Medicine dissertation focused on the treatment of syphilis with subcutaneous injections of sublimate. From 1876, A.I. Pospelov worked at the Myasnitsky Hospital as a senior physician (chief physician), where a "Syphilitic Department for the Labor Class" was established in the early 20th century. His name is associated with the launch of the hospital’s pathology department and reforms to the prostitution supervision system. The first meeting of the Moscow Society of Dermatovenereologists and Cosmetologists was held under the chairmanship of A.I. Pospelov. Professor A.I. Pospelov was the head of the Department of Skin and Venereal Diseases at Moscow University.
Other reports addressed differential diagnosis and therapy of psoriasis and seborrheic dermatitis, improving the quality of life of patients with eczema and atopic dermatitis, the efficacy of bacteriorhodopsin in psoriasis treatment, and the use of general aerocryotherapy in dermatology.
497-506
PHOTO GALLERY
Photo gallery. Parasitic dermatoses
Abstract
Parasitic dermatoses retain significance due to their high prevalence in contemporary society. The most frequently encountered diseases are scabies and pediculosis. These dermatoses are commonly observed in groups of individuals living together (nursing homes, psychiatric hospitals, hospices, dormitories, orphanages, or barracks). Poor socio-hygienic conditions and non-compliance with personal hygiene rules also contribute to disease development.
Scabies is a zoonotic dermatosis caused by the scabies mite Sarcoptes scabiei hominis. It is characterized by intensely pruritic eruptions and the presence of scabies burrows, which is a pathognomonic sign. It develops at any age, although it is most frequently encountered in children and elderly individuals. Severe forms of the disease include scabies lymphoplasia, scabies erythrodermia, and Norwegian scabies.
Pediculosis is caused by blood-sucking insects ― lice. Three species of lice parasitize human skin: head louse (Pediculus humanus capitis), body louse (Pediculus humanus corporis), and pubic louse (Pthirus pubis). Complications of pediculosis include pyodermias and allergic dermatitis; it should also be noted that lice are vectors of typhus.
Myiasis is a parasitic disease caused by larvae of dipterous flies (Dermatobia hominis). Lesions are frequently detected on the face and scalp, presented as nodules from which serous-purulent contents may be discharged.
Onchocerciasis (“river blindness”) is a chronic parasitic disease caused by the filarial nematode Onchocerca volvulus. It is characterized not only by skin involvement but also frequently by severe ocular damage.
Cutaneous leishmaniasis is a vector-borne human disease attributable to the unicellular, flagellated protozoan Leishmania tropica. The infection is transmitted by sandflies of the genus Phlebotomus, with Phlebotomus papatasi being the principal vector.
Trombidiasis is a disease caused by the penetration into the skin of larval mites of the genus Trombidiidae (family Trombiculidae). The infection manifests as local inflammation, papule formation, and erythema at the site of larval insertion.
The photo gallery presents various cases of parasitic dermatoses and their causative agents.
507-512




